Cetera Investment Advisers »

Halozyme Therapeutics shares owned by Cetera Investment Advisers

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Cetera Investment Advisers from 13F filings

Historical chart of Cetera Investment Advisers investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Cetera Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Cetera Investment Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.5M 54k 64.63
2025-12-31 $3.7M 55k 67.30
2025-09-30 $4.4M 60k 73.34
2025-06-30 $2.4M 46k 52.02
2025-03-31 $2.9M 45k 63.81
2024-12-31 $2.0M 42k 47.81
2024-09-30 $2.2M 39k 57.24
2024-06-30 $1.4M 28k 52.36
2024-03-31 $772k 19k 40.68